LABS · MediPharm Labs Corp. · Insider Trading
Market Cap
25.63M CAD
Shares
427.18M
Volume · Nov 6
80.4K
Avg daily vol (3M)
128.42K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in MediPharm Labs Corp. securities by its insiders (directors, officers and significant shareholders) as filed on SEDI, the Canadian Securities Administrators' insider disclosure system.
Insider transactions
Insider transactions as filed on SEDI, each amended transaction at its newest amendment only. Capture began with about the year before its first read and grows daily, so older history is not included. Amounts are signed (negative for a disposition) and counted in the units of the security named, which may be options, share units or warrants rather than shares. Prices are in the stated currency. Holding after is the insider's balance of that security after the transaction, as filed.
| Transaction date | Insider | Transaction | Security | Amount | Price | Holding after | Filed |
|---|---|---|---|---|---|---|---|
| 2026-09-09 | Hunter, Gregory Edison Senior Officer of Issuer | Grant of rights | Restricted Stock UnitsUnderlying: Common Shares | +401,069 | 2,053,211Direct | 2026-09-14 | |
| 2026-01-01 | Bumby, Michael Scott Director of Issuer | Opening Balance-Initial SEDI Report | Restricted Stock UnitsUnderlying: Common Shares | 0 | 642,857Direct | 2026-01-08 | |
| 2026-01-01 | Bumby, Michael Scott Director of Issuer | Opening Balance-Initial SEDI Report | Common Shares | 0 | 461,092Direct | 2026-01-08 | |
| 2025-12-09 | Taves, Christopher David Director of Issuer | Grant of rights | Restricted Stock UnitsUnderlying: Common Shares | +392,857 | 392,857Direct | 2025-12-14 | |
| 2025-12-09 | Taves, Christopher David Director of Issuer | Exercise of rights | Common Shares | +392,858 | 2,631,868Direct | 2025-12-14 | |
| 2025-12-09 | Taves, Christopher David Director of Issuer | Exercise of rights | Restricted Stock UnitsUnderlying: Common Shares | -392,858 | 0Direct | 2025-12-14 | |
| 2025-12-09 | Potts, Shelley Donne Director of Issuer | Exercise of rights | Common Shares | +74,683 | 310,223Direct | 2025-12-14 | |
| 2025-12-09 | Potts, Shelley Donne Director of Issuer | Exercise of rights | Restricted Stock UnitsUnderlying: Common Shares | -160,714 | 0Direct | 2025-12-14 | |
| 2025-12-09 | Strachan, Keith Director of Issuer | Grant of rights | Restricted Stock UnitsUnderlying: Common Shares | +321,429 | 582,898Direct | 2025-12-14 | |
| 2025-12-09 | Strachan, Keith Director of Issuer | Exercise of rights | Common Shares | +313,136 | 3,653,997Direct | 2025-12-14 | |
| 2025-12-09 | Strachan, Keith Director of Issuer | Exercise of rights | Restricted Stock UnitsUnderlying: Common Shares | -673,846 | 261,469Direct | 2025-12-14 | |
| 2025-12-09 | Halyk, Christopher John Director of Issuer | Grant of rights | Restricted Stock UnitsUnderlying: Common Shares | +178,571 | 178,571Direct | 2025-12-14 | |
| 2025-12-09 | Halyk, Christopher John Director of Issuer | Exercise of rights | Common Shares | +82,982 | 430,692Direct | 2025-12-14 | |
| 2025-12-09 | Halyk, Christopher John Director of Issuer | Exercise of rights | Restricted Stock UnitsUnderlying: Common Shares | -178,572 | 0Direct | 2025-12-14 | |
| 2025-12-09 | Medland, John Director of Issuer | Grant of rights | Restricted Stock UnitsUnderlying: Common Shares | +321,429 | 321,429Direct | 2025-12-14 | |
| 2025-12-09 | Medland, John Director of Issuer | Exercise of rights | Common Shares | +32,633 | 165,266Direct | 2025-12-14 | |
| 2025-12-09 | Medland, John Director of Issuer | Exercise of rights | Restricted Stock UnitsUnderlying: Common Shares | -70,225 | 0Direct | 2025-12-14 | |
| 2025-12-09 | Hunter, Gregory Edison Senior Officer of Issuer | Grant of rights | Restricted Stock UnitsUnderlying: Common Shares | +732,857 | 741,857Direct | 2025-12-14 | |
| 2025-12-09 | Hunter, Gregory Edison Senior Officer of Issuer | Exercise of rights | Common Shares | +589,428 | 2,909,794Direct | 2025-12-14 | |
| 2025-12-09 | Hunter, Gregory Edison Senior Officer of Issuer | Exercise of rights | Restricted Stock UnitsUnderlying: Common Shares | -1,268,407 | 9,000Direct | 2025-12-14 | |
| 2025-12-09 | Jameson, Emily Director of Issuer | Grant of rights | Restricted Stock UnitsUnderlying: Common Shares | +357,143 | 357,143Direct | 2025-12-14 | |
| 2025-12-09 | Jameson, Emily Director of Issuer | Exercise of rights | Common Shares | +32,633 | 65,266Direct | 2025-12-14 | |
| 2025-12-09 | Jameson, Emily Director of Issuer | Exercise of rights | Restricted Stock UnitsUnderlying: Common Shares | -70,225 | 0Direct | 2025-12-14 | |
| 2025-12-09 | Pidduck, David Director of Issuer | Grant of rights | Restricted Stock UnitsUnderlying: Common Shares | +1,208,571 | 1,208,571Direct | 2025-12-14 | |
| 2025-12-09 | Pidduck, David Director of Issuer | Exercise of rights | Common Shares | +1,308,053 | 22,492,428Direct | 2025-12-14 | |
| 2025-12-09 | Pidduck, David Director of Issuer | Exercise of rights | Restricted Stock UnitsUnderlying: Common Shares | -2,814,835 | 0Direct | 2025-12-14 | |
| 2025-12-09 | Bumby, Michael Scott Director of Issuer | Grant of rights | Restricted Stock UnitsUnderlying: Common Shares | +642,857 | 642,857Direct | 2025-12-14 | |
| 2025-12-09 | Bumby, Michael Scott Director of Issuer | Exercise of rights | Common Shares | +82,981 | 461,092Direct | 2025-12-14 | |
| 2025-12-09 | Bumby, Michael Scott Director of Issuer | Exercise of rights | Restricted Stock UnitsUnderlying: Common Shares | -178,571 | 0Direct | 2025-12-14 |
29 transactions between 2025-12-09 and 2026-09-09. Checked 2026-11-08 16:08 UTC.
Showing 1–29 of 29 transactions